Stratis Group
Tim Szymusiak has a diverse work experience in the pharmaceutical and healthcare industry. Tim is currently serving as the Head of Market Access & Reimbursement at Stratis Group since June 2022. Prior to this, Tim held senior positions in various prominent companies such as Bristol Myers Squibb, Celgene, kaleo, Auxilium Pharmaceuticals, EKR Therapeutics, Enzon Pharmaceuticals, Ovation Pharmaceuticals, and Mylan-Bertek Pharmaceuticals. Tim has demonstrated expertise in roles related to market access, reimbursement, patient support, trade, distribution, and key account management.
Tim Szymusiak attended Illinois State University from 1993 to 1997 and earned a degree in Biology with a focus on Biochemistry. Tim then went on to pursue an MBA in Marketing at Roosevelt University from 1998 to 2001.
This person is not in any offices
Stratis Group
Stratis Group combines primary research initiatives with cutting-edge analytics to deliver clear, actionable strategy. We work with clients across pharmaceutical, biotechnology, and academic industries. At Stratis Group, we bring together a long history of developing and delivering focused strategy for clients, with engagement targets ranging from some of the largest and most complicated brands to early-stage portfolios. Our team has decades of experience in the pharmaceutical industry, with a foundation in both industry and consulting. Every individual brings a range of cross-functional experience across managed care, academic research, finance, public health, and hospital administration. While becoming a part of our clients’ teams, we thrive on solving complex brand challenges that require both deep experience and innovative thinking.